Abstract:
OBJECTIVE:The primary objective of the TEENZ Study (NCT01211145) was to assess the efficacy of zolmitriptan nasal spray in the acute treatment of adolescent migraine patients (ages 12 to 17 years), as measured by the primary outcome variable of pain-free status at 2 hours post-treatment. METHODS:This randomized, double-blind, placebo-controlled, four-arm parallel group study compared zolmitriptan nasal spray with placebo in the treatment of a single episode of adolescent migraine. Patients completed a 30-day run-in period to treat a single migraine attack with single-blind placebo nasal spray. Eligible patients, who had not responded to placebo, were randomized to one of three zolmitriptan nasal spray doses (5, 2.5, or 0.5 mg) or placebo in a ratio of 5:3:3:5 according to a computer-generated randomization scheme. Patients completed diaries for 24 hours after treatment, recording headache pain scores, adverse events (AEs), and medications taken. RESULTS:In an interim futility analysis, zolmitriptan nasal spray doses of 0.5 and 2.5 mg were declared futile relative to placebo and further randomization to these treatment arms was discontinued. Of 1653 patients enrolled into the study, 855 patients failed to meet study eligibility criteria and were considered screen failures. The most common reason for screen failure was response to placebo challenge (325 patients [38.0%]). Of the 798 patients who were randomized to treatment, 721 (90.4%) completed the study period. Of these, 657 (82.3%) treated a migraine within the study period and contributed data for analysis. Zolmitriptan nasal spray 5 mg was significantly more effective than placebo in achieving pain-free status at 2 hours after treatment (P < .001), with 30% of patients achieving pain-free status at 2 hours vs 17% of placebo-treated patients (OR 2.18; 95% CI 1.40, 3.39). Zolmitriptan nasal spray 5 mg was also more effective than placebo in achieving pain-free status at 3 and 4 hours post-treatment (45 vs 24%, and 56 vs 39%; both P < .001). Zolmitriptan nasal spray 5 mg was also more effective than placebo in achieving headache response at 2, 3, and 4 hours after treatment (51 vs 39%, 61 vs 48%, and 69 vs 57%, respectively; all P ≤ .011). Zolmitriptan nasal spray was well-tolerated at all doses. Dysgeusia was the most frequently reported AE, with greater frequencies reported in active treatment groups versus placebo. No serious AEs or AEs leading to discontinuation were reported. Most AEs were mild or moderate in severity, and consistent with the known profile of zolmitriptan in adult and adolescent populations. CONCLUSION:Zolmitriptan nasal spray was well-tolerated in the acute treatment of adolescent (ages 12 to 17 years) migraine. Zolmitriptan 5 mg nasal spray demonstrated superior efficacy compared with placebo for the primary efficacy endpoint of pain-free status 2 hours after treatment and the efficacy of the 5 mg dose was supported by the majority of secondary efficacy endpoints.
journal_name
Headachejournal_title
Headacheauthors
Winner P,Farkas V,Štillová H,Woodruff B,Liss C,Lillieborg S,Raines S,TEENZ Study Group.doi
10.1111/head.12859subject
Has Abstractpub_date
2016-07-01 00:00:00pages
1107-19issue
7eissn
0017-8748issn
1526-4610journal_volume
56pub_type
杂志文章,多中心研究,随机对照试验相关文献
HEADACHE文献大全abstract:OBJECTIVE:To explore the effects of olmesartan on frequency and severity of migraine attacks in patients with comorbid hypertension and prehypertension. BACKGROUND:A randomized, double-blind, placebo-controlled, crossover study with a total of 60 patients has demonstrated the efficacy and safety of the angiotensin II ...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/j.1526-4610.2006.00382.x
更新日期:2006-03-01 00:00:00
abstract::The intimate relationship between sleep and headache has been recognized for centuries, yet the relationship remains clinically and nosologically complex. Headaches associated with nocturnal sleep have often been perceived as either the cause or result of disrupted sleep. An understanding of the anatomy and physiology...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2003.03055.x
更新日期:2003-03-01 00:00:00
abstract::We report the case of a man who suffered from Valsalva-induced cluster headaches. The headaches deviated from classic cluster in that they were solely induced by activity involving the Valsalva maneuver, such as coughing and sneezing, and never occurred spontaneously. The attacks were prevented by treatment with indom...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2002.02088.x
更新日期:2002-04-01 00:00:00
abstract:OBJECTIVES:To monitor for a signal of major teratogenicity by determining the risk of all major defects following in utero exposure to sumatriptan and naratriptan. To monitor for unusual patterns of birth defects that might suggest teratogenicity. BACKGROUND:The prevalence of migraine is highest in women of childbeari...
journal_title:Headache
pub_type: 杂志文章,多中心研究
doi:10.1111/j.1526-4610.2009.01529.x
更新日期:2009-11-01 00:00:00
abstract::Neurotologic symptoms are common with migraine, yet relatively little is known about the pathophysiology of such symptoms. Motion sensitivity with bouts of motion sickness occurs in about two thirds of patients with migraine. Episodes of vertigo occur in about one fourth of patients and, in some, vertigo is the only s...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1046/j.1526-4610.1997.3710615.x
更新日期:1997-11-01 00:00:00
abstract::Migraine and stroke are the most common neurovascular disorders affecting adults. Migraine, particularly with aura, is associated with increased stroke risk both during and between attacks; as such, migraine may be viewed as a potentially modifiable risk factor for stroke. The exact mechanism by which migraine can pre...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12115
更新日期:2013-06-01 00:00:00
abstract:OBJECTIVE:To evaluate the effect of different migraine prophylaxis medications on subject responsiveness to almotriptan. BACKGROUND:There is evidence supporting an increase of responsiveness of symptomatic medications for migraine attacks by some prophylactic treatments although this has not been probed. METHODS:A to...
journal_title:Headache
pub_type: 临床试验,杂志文章
doi:10.1111/j.1526-4610.2009.01491.x
更新日期:2009-10-01 00:00:00
abstract:BACKGROUND:Zonisamide, a sulfonamide analog, is an antiepileptic drug with mechanisms of action similar to topiramate. Because of its pharmacodynamic and pharmacokinetics profiles, zonisamide is also potentially suitable for migraine prevention. METHODS:Tolerability and effectiveness of zonisamide for migraine prophyl...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2010.01842.x
更新日期:2011-02-01 00:00:00
abstract::This paper describes the development and validation of a migraine-specific quality-of-life instrument that is capable of measuring health-related quality-of-life impairments attributed to migraine. Item selection, item reduction, and pretesting and finalization of items during the instrument development phase resulted...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1998.3804295.x
更新日期:1998-04-01 00:00:00
abstract::In a data base of 1013 patients with chronic headache, 44.1% reported the onset of headaches before the age of 20 (preadult-onset headache) and 55.9% at or after that age (adult-onset headache). Circumstances of headache onset were mentioned significantly more frequently in the latter than in the former group (8.5% ve...
journal_title:Headache
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1046/j.1526-4610.1999.3905317.x
更新日期:1999-05-01 00:00:00
abstract:OBJECTIVE:To examine the efficacy of L-kynurenine and a novel kynurenic acid derivative on the nitroglycerin-induced calmodulin-dependent protein kinase II alpha (CamKIIalpha) and calcitonin gene-related peptide (CGRP) expression changes in the rat caudal trigeminal nucleus. BACKGROUND:Systemic administration of the n...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01574.x
更新日期:2010-05-01 00:00:00
abstract:OBJECTIVE:To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset. BACKGROUND:CH patients are presenting a hig...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.13516
更新日期:2019-04-01 00:00:00
abstract::Unilateral hairlike discoloration of the tongue is described in a patient with ipsilateral mandibular division trigeminal neuralgia. This unusual physical sign coincided with the patient's painful trigger zone and was attributed to hypertrophy of keratinized filiform papillae, where guarded avoidance of mechanical sti...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2004.04173.x
更新日期:2004-10-01 00:00:00
abstract:OBJECTIVE:To investigate the habituation response pattern of patients with migraine to a simple standard stressor and to a more complex performance-dependent (achievement) stressor in three peripheral systems (electrodermal, vasomotor, and cardiovascular). We hypothesized that the migraine patients would show abnormal ...
journal_title:Headache
pub_type: 临床试验,杂志文章
doi:10.1111/j.1526-4610.2005.00270.x
更新日期:2005-11-01 00:00:00
abstract::Two cases of baroreflex failure presented with tension-type/exertional headache. The usefulness of noninvasive physiological tests in diagnosing baroreflex failure and the role of baroreceptors in trigeminal nociception are discussed. ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00514_3.x
更新日期:2006-07-01 00:00:00
abstract::Traditionally, episodic primary headache disorders are characterized by a return of preheadache (normal) neurologic function between episodes of headache. In contrast, patients with chronic headache often do not return to normal neurologic function between headache attacks. This article proposes that the evolution fro...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2004.04094.x
更新日期:2004-05-01 00:00:00
abstract:BACKGROUND:Several studies suggest an association between migraine and juvenile stroke. Because of some shortcomings, we designed another case-control study of a homogenous group of patients with juvenile cerebral ischemia. This study is part of a larger German epidemiological research project on the association of mig...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2003.03023.x
更新日期:2003-02-01 00:00:00
abstract:OBJECTIVE:This post hoc study investigated the relationship between patient response in terms of migraine headache day reduction and patient-reported outcomes of health-related quality of life (HRQoL) and disability categories. BACKGROUND:Migraine causes considerable disease-related disability and negatively impacts H...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.14013
更新日期:2020-11-01 00:00:00
abstract:OBJECTIVES:In a randomized controlled trial extending over 6 months, we evaluated the effectiveness of acupuncture versus flunarizine in the prophylactic treatment of migraine without aura. METHODS:One hundred sixty women with migraines were randomly assigned to acupuncture treatment (group A, n = 80) or to an oral th...
journal_title:Headache
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1046/j.1526-4610.2002.02203.x
更新日期:2002-10-01 00:00:00
abstract:OBJECTIVE:To evaluate the relationships among modifiable psychological factors and chronic migraine and severe migraine-related disability in a clinic-based sample of persons with migraine. BACKGROUND:Evidence evaluating relationships between modifiable psychological factors and chronic migraine and severe migraine-re...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13021
更新日期:2017-04-01 00:00:00
abstract:OBJECTIVES/BACKGROUND:We herein investigated the role of polymorphisms in calcitonin gene-related peptide (CGRP)-related genes looking at the association of rs3781719 (T > C) in the calcitonin gene-related polypeptide-alpha (CALCA) gene and of rs3754701 (T > A) and rs7590387 (C > G) at the receptor activity modifying 1...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12559
更新日期:2015-05-01 00:00:00
abstract:BACKGROUND:Migraine occurs in 3% to 5% of young children and up to 18% of adolescents. Management requires a tailored regimen of pharmacological and behavioral measures that consider the headache burden and disability. Patients with frequent or disabling attacks (or both) may warrant preventive agents. OBJECTIVE:To in...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2004.04052.x
更新日期:2004-03-01 00:00:00
abstract:OBJECTIVE:To evaluate the prevalence of migraine/severe headaches in those with and without general obesity and abdominal obesity (Abd-O) and the effect of gender and age on this relationship. BACKGROUND:General, or total body obesity (TBO), as estimated by body mass index, is a risk factor for migraine chronification...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01459.x
更新日期:2010-01-01 00:00:00
abstract::This study examined the relationship between the menstrual cycle, the stress process, and migraines. Women migraineurs (N = 12) and a matched control sample (N = 12) completed a set of questionnaires assessing stress, appraisal, and coping at premenses, menses, and ovulation. In addition, migraineurs completed a month...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1996.3609531.x
更新日期:1996-10-01 00:00:00
abstract:BACKGROUND:New treatments are needed to treat chronic daily headache (CDH) and chronic cluster headache (CCH). New treatments are needed to treat this population and intravenous (IV) lidocaine is a novel treatment for CDH. OBJECTIVE:The aim of this study was to examine the use of IV lidocaine for refractory CDH patien...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01281.x
更新日期:2009-02-01 00:00:00
abstract:BACKGROUND:Olanzapine, a thienobenzodiazepine, is a new "atypical" antipsychotic drug. Olanzapine's pharmacologic properties suggest it would be effective for headaches, and its propensity for inducing acute extrapyramidal reactions or tardive dyskinesia is relatively low. We thus decided to assess the value of olanzap...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2002.02126.x
更新日期:2002-06-01 00:00:00
abstract:OBJECTIVES:To assess the measurement properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQv2.1) electronic patient-reported outcome (ePRO) Role Function-Restrictive (RFR) domain to evaluate the functional impact of migraine in patients with episodic (EM) or chronic migraine (CM) enrolled in...
journal_title:Headache
pub_type: 杂志文章,多中心研究,随机对照试验
doi:10.1111/head.13497
更新日期:2019-05-01 00:00:00
abstract::Hemicrania continua (HC) is a rare type of primary headache characterized by a prompt and enduring response to indomethacin. We describe a patient who suffered from cluster headache evolving into ipsilateral HC, who does not tolerate a long-term indomethacin therapy. The case was complex in terms of diagnosis, associa...
journal_title:Headache
pub_type: 信件
doi:10.1111/j.1526-4610.2008.01249.x
更新日期:2008-10-01 00:00:00
abstract::A 29-year-old woman presented with acute hemicrania, trigeminal neuropathy and posterior fossa dysfunction. The admission differential diagnosis included vertebral artery dissection, posterior circulation aneurysm, vascular malformation and brainstem infarction. However, radiographic and CSF studies indicated demyelin...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1989.hed2907423.x
更新日期:1989-07-01 00:00:00
abstract::Two patients suffering from SUNCT syndrome are presented. Some features are remarkable. The first patient was a 69-year-old man whose first crisis was located in the right supraorbital region. After a 4-month spontaneous remission, the pain returned to the upper part of the cheek, radiating to the supraciliary region ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1998.3805369.x
更新日期:1998-05-01 00:00:00